<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39197648</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-6424</ISSN><JournalIssue CitedMedium="Internet"><Volume>361</Volume><PubDate><Year>2024</Year><Month>Aug</Month><Day>27</Day></PubDate></JournalIssue><Title>Environmental pollution (Barking, Essex : 1987)</Title><ISOAbbreviation>Environ Pollut</ISOAbbreviation></Journal><ArticleTitle>High-throughput transcriptomics toxicity assessment of eleven data-poor bisphenol A alternatives.</ArticleTitle><Pagination><StartPage>124827</StartPage><MedlinePgn>124827</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.envpol.2024.124827</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0269-7491(24)01541-0</ELocationID><Abstract><AbstractText>Bisphenol A (BPA), a widely used chemical in the production of plastics and epoxy resins, has garnered significant attention due to its association with adverse health effects, particularly its endocrine-disrupting properties. Regulatory measures aimed at reducing human exposure to BPA have led to a proliferation of alternative chemicals used in various consumer and industrial products. While these alternatives serve to reduce BPA exposure, concerns have arisen regarding their safety and potential toxicity as regrettable substitutes. Previous efforts have demonstrated that in vitro high-throughput transcriptomics (HTTr) studies can be used to assess the endocrine-disrupting potential of BPA alternatives, and this strategy produces transcriptomic points-of-departure (tPODs) that are protective of human health when compared to the PODs from traditional rodent studies. In this study, we used in vitro HTTr to assess the potential for toxicity of eleven data-poor legacy chemicals sharing structural similarities to BPA. Human breast cancer MCF-7 cells were exposed to BPA and 11 alternatives at concentrations ranging from 0.1 to 25 μM to assess toxicity. Analysis of global transcriptomic changes and a previously characterized estrogen receptor alpha (ERα) transcriptomic biomarker signature revealed that 9 of 11 chemicals altered gene expression relative to controls. One of the chemicals (2,4'-Bisphenol A) activated the ERα biomarker at the same concentration as BPA (i.e., 4,4'-BPA) but was deemed to be more potent as it induced global transcriptomic changes at lower concentrations. These results address data gaps in support of ongoing screening assessments to identify BPA alternatives with hazard potential and help to identify potential candidates that may serve as safer alternatives.</AbstractText><CopyrightInformation>Crown Copyright © 2024. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Beal</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Bureau of Chemical Safety, Health Products and Food Branch, Health Canada, Canada. Electronic address: marc.beal@hc-sc.gc.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coughlan</LastName><ForeName>Melanie C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Bureau of Chemical Safety, Health Products and Food Branch, Health Canada, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nunnikhoven</LastName><ForeName>Andrée</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Bureau of Chemical Safety, Health Products and Food Branch, Health Canada, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gagné</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Existing Substances Risk Assessment Bureau, Healthy Environments and Consumer Safety Branch, Health Canada, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barton-Maclaren</LastName><ForeName>Tara S</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Existing Substances Risk Assessment Bureau, Healthy Environments and Consumer Safety Branch, Health Canada, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bradford</LastName><ForeName>Lauren M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Environmental Health Science and Research Bureau, Healthy Environments and Consumer Safety Branch, Health Canada, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rowan-Carroll</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Environmental Health Science and Research Bureau, Healthy Environments and Consumer Safety Branch, Health Canada, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Environmental Health Science and Research Bureau, Healthy Environments and Consumer Safety Branch, Health Canada, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meier</LastName><ForeName>Matthew J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Environmental Health Science and Research Bureau, Healthy Environments and Consumer Safety Branch, Health Canada, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Environ Pollut</MedlineTA><NlmUniqueID>8804476</NlmUniqueID><ISSNLinking>0269-7491</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bisphenol A</Keyword><Keyword MajorTopicYN="N">Endocrine disruption</Keyword><Keyword MajorTopicYN="N">MCF-7</Keyword><Keyword MajorTopicYN="N">New approach methodologies</Keyword><Keyword MajorTopicYN="N">Regrettable substitutions</Keyword><Keyword MajorTopicYN="N">Toxicogenomics</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>28</Day><Hour>19</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39197648</ArticleId><ArticleId IdType="doi">10.1016/j.envpol.2024.124827</ArticleId><ArticleId IdType="pii">S0269-7491(24)01541-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle>